Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$25.1 - $53.8 $33.6 Million - $72 Million
-1,338,760 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$16.0 - $40.99 $5.3 Million - $13.6 Million
-331,307 Reduced 19.84%
1,338,760 $54.9 Million
Q1 2020

May 15, 2020

SELL
$7.79 - $19.91 $574,123 - $1.47 Million
-73,700 Reduced 4.23%
1,670,067 $31.4 Million
Q4 2019

Feb 14, 2020

SELL
$8.01 - $12.48 $165,831 - $258,373
-20,703 Reduced 1.17%
1,743,767 $21.2 Million
Q3 2019

Nov 14, 2019

BUY
$8.7 - $23.46 $3.13 Million - $8.45 Million
360,000 Added 25.63%
1,764,470 $16.7 Million
Q2 2019

Aug 14, 2019

BUY
$15.75 - $23.0 $2.49 Million - $3.64 Million
158,155 Added 12.69%
1,404,470 $32.3 Million
Q1 2019

May 15, 2019

BUY
$16.02 - $22.17 $320,400 - $443,400
20,000 Added 1.63%
1,246,315 $24.5 Million
Q4 2018

Feb 14, 2019

BUY
$15.98 - $21.0 $19.6 Million - $25.8 Million
1,226,315 New
1,226,315 $24.5 Million

Others Institutions Holding VAPO

About VAPOTHERM INC


  • Ticker VAPO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,697,200
  • Market Cap $57.9M
  • Description
  • Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...
More about VAPO
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.